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Expression of HLA-DQ, -DR, and -DP antigens in normal kidney and
glomerulonephritis. Expression of the defined subtypes of H LA-class II
antigens DQ, DR, DP, as well as of a putatively new HLA-class II
determinant DY was evaluated with specific monoclonal antibodies on
frozen sections of 15 normal kidneys, as well as of renal tissue of 65
patients with different forms of glomerulonephritis (ON). In normal
kidney HLA-DR and/or -DY versus DQ or DP antigens were shown to
be differentially expressed on subpopulations of glomerular and inter-
stitial cells, as well as vascular endothelia. Normal proximal tubular
epithelia lacked HLA-DQ and -DP antigens, but carried -DY and
variably -DR products constitutively. In comparison, aberrant presence
of HLA-DQ and/or -DP antigens was found on proximal tubular cells in
the majority of patients with rapidly progressive (RPGN), membrano-
proliferative ON (MPGN), or focal glomerular sclerosis (FGS), but
more rarely observed in other forms of proliferative or non-proliferative
ON. In addition all cases with RPGN revealed reduction of HLA-DQ,
-DR, -DP or -DY+ glomerular cells. Decline of HLA-DP and/or -DR+
glomerular cells was variably seen in mesangioproliferative glomerulo-
nephritis (MesPGN) and MPGN, whereas in FGS HLA-DQ antigens
appeared to be increased in glomeruli. HLA-DQ, -DR. -DY+ interstitial
cellular infiltrates were present in RPGN, FGS and MPGN and only
occasionally occurred in other forms of GN. Altered renal expression of
HLA-class II antigens may indicate specific sites of immunologically-
mediated kidney injuries in GN.
The major histocompatibility complex in man comprises
three main HLA-class II loci, DR, DQ, DP, which encode
polymorphic cell surface products composed of a light (a) and a
heavy (f3) polypeptide chain with characteristic serological and
biochemical properties [reviewed in 1, 2]. HLA-DR, -DQ and
-DP products have been shown to restrict recognition of foreign
antigens by T-lymphocytes [3—5]. Although primarily present
on cells of the immune system, HLA-class II molecules are also
found on a variety of non-bone marrow derived cells in different
organs [6, 7] and therefore are likely to play an important role in
regulation of local tissue immune responses. During recent
years monoclonal reagents were characterized by serologically
distinguishing products of the HLA-class II subloci [8, 91. Use
of these antibodies revealed differential distribution of HLA-
DR, -DQ and -DP antigens in various tissues [7, 10].
In normal kidney, HLA-class II antigens have been demon-
strated on glomerular mesangial, interstitial dendritic and cap-
illary endothelial cells, but variably on proximal tubular epi-
thelia [11—17]. Recently, increased tubular expression of HLA-
class II molecules has been recognized in renal allografts in
correlation with rejection [18—20]. Furthermore, in a few cases
of glomerulonephritis class II antigens were found to be aber-
rantly present on tubular epithelia [211. With the use of mono-
clonal antibodies differentiating products of the various HLA-
class II subloci, simultaneous presence of HLA-DQ, -DR and
-DP antigens on glomerular and peritubular capillary endothelia
in normal kidney has been described [7].
In this study expression of the defined subtypes of HLA-class
II antigens, DQ, DR, DP, as well as of a putatively new
HLA-class II DR-, DQ-, DP-negative determinant DY detected
by the mAB TU39 was evaluated on further structures in
normal adult kidneys and compared to their distribution in
glomerulonephritis (GN) to reveal alterations as sign of local
abnormal immune responses.
Methods
Kidney tissue
Diagnostic kidney biopsies were obtained from 65 patients
with different forms of GN before treatment (Table 1). For
comparison normal renal tissue was available from biopsies of
13 grafts before transplantation, as well as from two organs
which could not be grafted because of vascular abnormalities.
One part of all kidney specimens was processed routinely for
light microscopical, inimunohistochemical and electronmicro-
scopical analysis. The other part of the tissue samples was put
into cell culture medium (RPM! 1640, Gibco Biocult, Glasgow,
UK) immediately after removal, snap frozen and stored in
liquid nitrogen. Five-mu-thick frozen tissue sections cut from
each biopsy were fixed in aceton for 10 minutes after lyophili-
zation for two hours and used for immunostaining.
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Monoclonal antibodies (mAB)
Production, specificity and Ig-class of the applied monomor-
phic monoclonal antibodies TU22 (anti-DQ), TU34 (anti-DR)
and TU39 (anti-DR and -DP) have been described previously [5,
8—10, 22, 23]. In addition to HLA-DR and -DP molecules TU39
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Table 1. Histological diagnosis of the analyzed kidney biopsies with different forms of glomerulonephritis (GN)
Diagnosis
Number of Primary
Abbreviation biopsies disease
Timing of biopsy
from apparent onset
months
Rapidly progressive ON
Mesangioproliferative GN
Membranoproliferative ON type I
Minor lesions
Minimal changes
Perimembranous ON
Focal glomerular skierosis
RPGN 10 SLE (4)
Goodpasture (I)
MesPGN 18 SLE (1)
MPGN 6 Diabetes mellitus (1)
ML 3 —
MCH 6 —
PGN 10 —
FGS 11 —
0.5—42
0.5—72
3—60
12—72
0.5—28
0.5—72
0.75—204
a Systemic lupus erythematosus
Table 2. Distribution of HLA-DQ, -DR, -DP antigens in normal adult kidneys (N = 15)
Renal structures
Expression of HLA-clats II antigens
TU22+ DQ TU34+ DR B7/21+ DP T039+ DR/DP/DY
Glomerular cells + + + + + + +
Tubular cells
proximal
Henle's loop
distal
collecting duct (medulla)
— + + a —
— — —
— — —
— ++C +c
+ + +
++I'
—
+++'
Intertubular structures
large vessels
capillaries
interstitial cells
— + +
+ + + + +
+ + + +
+
+ + +
+ +
— no labeling of all cases
+ labeling on single specific cells
+ + labeling on few specific cells
+ + + labeling on many specific cells
a 9 out of 15 analyzed casesb 3 out of 15 analyzed cases
4 out of 6 analyzed cases
has been shown to recognize a further HLA-class II antigen,
DY, differentiated by T-cell clones from defined products [24].
B7/21 (anti-DP) supernatant [25, 26] was provided by Dr. F.
Bach (Institute of Immunology and Immunopathology, Minne-
apolis, Minnesota, USA). B7/21 hybridoma was from Dr. I.
Trowbridge (San Diego, California, USA). In all experiments,
the monoclonal reagent W6/32.HL (anti-HLA-ABC heavy
chain), was used as positive coPtrol [27], whereas W6/32.HK
(inactive variant of W6/32.HLK) [28] was applied to assess
nonspecific staining.
Immunohistology
Indirect immunoperoxidase staining was performed using
monoclonal reagents as primary and peroxidase-conjugated
rabbit anti-mouse Ig (Fa. Dako, Copenhagen, Denmark) as
secondary antibody layers exactly as previously described [10,
29]. To identify interstitial endothelia, intracellular alkaline
phosphatase was demonstrated subsequent to the immunoper-
oxidase staining for class H in double labelling experiments as
previously described [30]. All experiments included positive
and negative control sections labeled with W6/32.HL or W6/
32.HK as first antibodies.
Quantitative evaluation
All quantitative and qualitative evaluations of the normal and
pathological kidneys were made blind by the same two readers.
Immunohistological reaction intensity and/or quantity was eval-
uated separately for glomeruli, tubuli and interstitial cells.
Biopsies with five or more glomeruli were investigated. Be-
cause of variable confluent labelling, HLA-class II+cells within
glomeruli were evaluated semiquantitatively using arbitrary
scores: no staining (0), single positive cells (1), few positive
cells (2), many positive cells (3). According to this scale four
grades were given for glomerular staining of each biopsy. Mean
values calculated for each grade were added to compare quan-
tity of reaction with a single numerical number.
HLA-class 11+ mononuclear cells within the interstitium
were counted per "unit" using a standard eye piece graticule at
a magnification of x200 in a microscopic field of 0.16 mm2 on
serial sections.
Expression of HLA-DQ, -DR, -DP antigens on proximal
tubular cells identified morphologically, as well as by the mAB
TN1 [31] on serial sections, were graded 0 (no labelling), 1
(weak labelling of rare epithelia), 2 (moderate labelling of few
epithelia), 3 (strong labelling of all epithelia) on sequential
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Fig. 1. immunoperoxidase staining of
a frozen normal kidney section with the
monoclonal antibody TU39 reveals
expression of HLA-DRIDP/D Y antigens
on proximal tubular cells, as well as on
many glomerular cells (X120).
Table 3. Expression of HLA-class II antigens on proximal tubuli in different forms of GN in correlation with interstitial cellular infiltrates
Diagnosis
Total
number
of cases
Number of cases
with interstitial
infiltrates
Kidneys with HLA-class 11+ proximal tubuli interstitial infiltrates
Present Absent
DQ DR DPDQ DR DP
Proliferative GN
RPGN 10 10 a 7b 8b 0 0 0
MesPGN 18 6 3 6 4 4 11 5
MPGN 6 6 3 6 3 0 0 0
Non-proliferative GN
ML 3 2 0 2 2 0 1 0
MCH 6 0 0 0 0 2 6 2
PGN 10 2 0 2 2 0 8 2
FGS 12 12 7 12 7 0 0 0
a number of positive cases
b
analysis on nine cases
sections. For tubular staining of each section three grades were
given and intensity of reactivity expressed as sum of their
calculated mean values.
Results
Immunoperoxidase labelling patterns of four monoclonal
antibodies directed against the defined HLA-class II products
DQ, DR, DP and a putatively new HLA-D region determinant
DY were evaluated on 65 kidney biopsies of different prolifer-
ative and nonproliferative forms of UN in comparison with 15
normal kidneys. Presence of the HLA-D region determinant
DY could be evaluated by labelling of TU39 in the absence of
staining by TU34, TU22 and B7121 on renal tissue.
Glomerular cells
Normal. Semiquantitative evaluation of intraglomerular
HLA-class 11+ cells in 15 analyzed normal kidney biopsies
revealed TU39 + HLA-DRJDP/DY products on many of the
glomerular cells (Table 2, Fig. 1). The majority, but not all of
these cells were found to carry TU34+ HLA-DR antigens.
HLA-DQ antigens, however, were only observed on distinct
glomerular cells which appeared to be present within the
mesangium and rarely in capillaries (Fig. 2). HLA-DP antigens
were detected on a slightly larger cell population with similar
intraglomerular distribution.
Proliferative forms of GN. In comparison with normal renal
tissue a decrease of intraglomerular HLA-class 11+ cells was
seen in kidney biopsies of ten patients with rapidly progressive
glomerulonephritis (RPGN) (Fig. 3). In particular HLA-DQ and
-DP as well as to a minor extent HLA-DR antigens appeared to
be reduced within the glomerular tuft. In contrast, crescents in
RPGN frequently contained a large number of HLA-DQ, -DR
and -DP+ infiltrating cells (Fig. 4A). In six cases with membra-
noproliferative (MP), as well as in 18 patients with mesangio-
proliferative (MesP) GN mean labelling of glomerular cells by
TU39 was only slightly reduced, although it greatly varied
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Fig. 2. Immunoperoxidase staining of
a frozen normal kidney section with the
monoclonal antibody TU22 reveals
expression of HLA-DQ antigens on
distinct glomerular cells, but not on
proximal tubuli (x250).
Glomerular Cell index
within different renal biopsies. Decreased staining of TU34 or
B7/21, however, indicated specific reduction of HLA-DR or
-DP antigens in glomeruli of patients with MesPGN and MPGN,
(HLA-DQ) respectively.
H LA-DP)
lLA-DR, —DP, —DY)
Fig. 3. Comparison of mean values of semiquantitative assessment of
HLA-DQ, -DR, -DP, -DY positive glomeru/ar cells in normal kidney
and different forms of glomerulonephritis (mean values are based on an
arbitrary score as explained in Methods).
Normal. Staining of normal renal tissue with the monoclonal
antibody TU39 revealed presence of a determinant common to
HLA-DRJDP/DY antigens in all patients except one on proxi-
mal tubular cells, as well as in rare cases on distinct parts of
Henle's loop (Table 2, Fig. 1). None of the investigated normal
kidneys showed tubular expression of TU22+ HLA-DQ or B7/
21+ HLA-DP antigens. HLA-DR antigens, however, were
variably seen with the mAB TU34 on proximal tubular epithelia
in 9 of 15 kidneys.
Proliferative GN. TU39 detected HLA-class II products with
increased intensity on proximal tubular epithelia in all patients
with RPGN, MPGN and MesPGN (Fig. 5). Staining with TU34
distinguishing HLA-DR antigens on this part of the nephron in
the majority of these analyzed ON cases (7 of 9 with RPGN; 17
of 18 with MesPGN; 6 of 6 with MPGN). In RPGN eight out of
nine patients showed aberrant presence of HLA-DP antigens,
and in addition five had abnormal expression of HLA-DQ
antigens on proximal tubular epithelia. HLA-DQ + tubuli were
also found in three out of six patients with MPGN, as well as in
seven out of 18 cases with MesPGN. Three patients with
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(HLA-DR)
Non-proliferative forms of GN. Mean values of semiquanti-
tative assessment of HLA-DQ, -DR, or -DP+ glomerular cells
in minor lesions (ML), minimal changes (MCH) and perimem-
branous glomerulonephritis (PGN) were not significantly dif-
ferent from normal kidney (Fig. 3). In focal glomerular sclerosis
(FGS) reduction of HLA-DQ, -DR or -DP+ cells segmentally
varied with increases of HLA-class II + cells within glomeruli
(Fig. 4B). In spite of that, labelling of TU22 in FGS indicated
higher mean values of HLA-DQ+ glomerular cells than in
normal kidney.
Tubular epithelia
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Fig. 4. A. Immunoperoxidase staining
of a frozen section of a patient with
RPGN with the monoclonal antibody
TtJ39: Expression of HLA-DR/DP/DY
antigens on proximal tubular cells, as
well as in crescent formation of the
glomerulurn (x240), B.
Immunoperoxidase staining of a frozen
section from a patient with FOS with
the monoclonal antibody TU22:
Expression of HLA-DQ antigens is
demonstrated on proximal tubular cells,
but segmental loss of HLA-DQ
antigens is seen within the glomerulum
(x220).
MPGN and nine cases with MesPGN also showed tubular on proximal tubular epithelia. The latter cases were differenti-
staining for HLA-DP products. ated histologically as cell rich variant of MCH.
Non-proliferative GN. All proximal tubular epithelia in PGN,
ML, MCH and FGS were positive for TU39+ or TU34+ Tubular expression of class II antigens in correlation with
HLA-class II products to a higher variable intensity than interstitial infiltrates
normal. Aberrant tubular expression of HLA-DQ and -DP
antigens was found in seven of 12 cases with FGS and in two of Morphological and immunohistological evaluation of intersti-
six kidneys with MCH. Four patients with PGN and two tial mononuclear leukocyte infiltrates was performed in all
patients with ML only revealed HLA-DP antigens abnormally kidney biopsies analyzed [32]. Expression of HLA-DQ and/or
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Table 4. Mean values of absolute numbers of interstitial HLA-class I1+ cells counted per "unit" area
Diagnosis of
renal biopsies
Number
of cases
Interstitial cells
TU22+ DQ TU34+ DR B7/21 + DP TU39+ DRJDP/DY
Normals 15 25 5 26 5 21 7 30 8
Proliferative GN
RPGN 9 71 34 108 50 68 34 145 61
MesPGN
group I 6 63 29 71 38 44 19 130 50
group II 5 31 7 35 11 26 13 48 21
group III 8 25 10 43 24 27 12 52 32
MPGN 6 42 4 68 39 36 13 96 50
Non-proliferative GN
ML
group I 2 36 21 42 18 39 25 55 10
group II 1 46 90 54 87
MCH
group II 2 28 7 41 9 27 11 50 6
group III 2 35 10 36 2 27 2 53 8
PGN
group I 2 83 35 71 23 84 29 139 19
group II 1 30 38 24 37
group III 7 27 10 34 11 31 20 38 12
FGS 11 39 27 63 47 28 16 69 44
Group I, biopsies with interstitial T-cell infiltrates; group H, abnormal tubular HLA-DQ or -DP expression without interstitial T-cells; group III,
normal tubular class II expression without interstitial T-cells.
DP antigens on proximal tubular cells was found to be corre-
lated with the presence of interstitial cellular infiltrates in
RPGN, MPGN, ML and FGS (Table 3). In several cases of
PGN, MesPGN and MCH, however, HLA-DQ and/or -DP
antigens were also observed on tubular epithelia in the absence
of interstitial infiltrates.
HLA-class 11+ interstitial cells
Normal. In normal kidney TU39 stained a slightly larger
number of interstitial mononuclear cells than TU34, TU22 or
B7/21 (Table 4). Although double labelling experiments for
intracellular alkaline phosphatase permitted the identification of
endothelial cells, the precise nature of the HLA-class 11+
interstitial cells, that is, lymphocytes, monocytes, dendritic
cells or minute capillary endothelial cells, could not always be
definitely assessed by light microscopy.
Proliferative GN. Increased numbers of interstitial HLA-
class 11+ cells were identified by the mAB TU39 in all kidney
sections of RPGN, MesPGN and MPGN with histologically
identified infiltrates of mononuclear leukocytes. A large propor-
tion of these cells appeared to carry HLA-DR, -DQ and/or -DP
antigens. Since in all cases the highest number of HLA-class
11+ interstitial cells was detected by TU39, minor fractions
seemed to be negative for HLA-DQ, -DR and -DP, but positive
for the putative new HLA-class II determinant DY. In several
other cases of MesPGN only a slight increase of interstitial
HLA-class 11+ cells was seen compared to normal biopsies.
Non-proliferative GN. In PGN and FGS elevation of HLA-
DQ+, -DR+ and/or -DP+ cells also correlated with presence of
interstitial mononuclear infiltrates. In all cases except one with
ML and MCH only a slight increase of particularly TU39+
interstitial cells was observed.
Discussion
During recent years inducible and transient expression of
HLA-class II antigens has been described on many non-lym-
phoid cell types, with possible functional implications in im-
mune reactions [33, 34]. In this study, differential distribution of
HLA-DQ, -DR, -DP and of class II determinant DY is demon-
strated on glomerular and tubular cells of normal kidney. In
comparison, altered expression of these defined HLA-class II
products has been detected on glomerular, tubular and intersti-
tial structures in proliferative and non-proliferative forms of
glomerulonephritis.
In normal renal tissue HLA-DQ and -DP antigens were found
to be selectively present on interstitial dendritic cells, rare
capillary pentubular endothelia and few distinct glomerular
cells, which were not precisely identified by light microscopical
analysis. Tubular cells of all normal kidneys investigated lacked
HLA-DQ and -DP antigens. HLA-DR antigens, however, were
localized on endothelia of larger vessels, many glomerular cells
and some proximal tubular epithelia. A still wider renal expres-
sion of HLA-class II antigens was demonstrated with the mAB
TU39, recognizing further class II determinants DY on tubular
cells in all analyzed normal kidney sections except one. TU39+
positivity in the absence of DR, DQ, DP was observed not only
on proximal tubuli, but also on part of Henle's loop. Subpop-
ulations of glomerular and interstitial cells also appeared to
carry exclusively TU39+ HLA-class II antigens. Use of the
mABs at different concentrations excluded that the observed
differential staining patterns were due to variable antibody
titers. Although variance in antibody affinity or low epitope
density could not be ruled out, only HLA-DR and possibly a
new HLA-class II product DY, were detected to be physiolog-
ically present on proximal tubular epithelia. Thus these results
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N MesP ML PGN
RPGN MPGN MCH FGS
Tubular index
Fig. 5. Comparison of mean values of semiquantitatively assessed
staining intensity for HLA-DR, -DQ, -DP, -DY antigens on proximal
tubular cells in normal kidney and different forms of glomerulonephritis
(mean values are based on an arbitrary score as explained in Methods).
may partly explain previous inconsistent reports on tubular
expression of class II antigens [11—17]. Genetic factors as
reported in rats [35], as well as physiological stimuli of hor-
mones and immunological mediators [33, 36] may further deter-
mine the basal extent of lILA-DR and -DY antigens on tubular
cells.
In comparison with normal kidney, proliferative and non-
proliferative forms of GN specifically exhibited altered expres-
sion of HLA-DQ and -DP antigens on glomerular and tubular
cells. Reduction of HLA-DQ and/or -DP antigens in glomeruli
of RPGN and MPGN seemed to be due primarily to alterations
of intrinsic class 11+ cells present in the mesangium and in
capillaries. T-lymphocyte and monocyte subpopulations infil-
trating glomeruli in different forms of GN [32, 371 were likely to
elevate glomerular expression of class II antigens during acti-
vation, and thus could be related to an increase of HLA-DQ+
glomerular cells in FGS. Minor variations of glomerular HLA-
DR, -DQ, -DP antigens seemed to be present also in all other
forms of GN. In addition, in the majority of cases with RPGN
and FGS, induction of HLA-DQ and/or -DP antigens on prox-
imal tubular cells was seen, whereas it occurred more rarely in
other types of GN. Labelling for HLA-DR and/or -DY deter-
minants revealed increased levels of HLA-class II molecules on
proximal tubular cells in all GN cases analyzed. As in animal
models of graft-versus-host disease [38] and allorejection reac-
tions in renal transplants [39] increased production of MHC
antigens in tubular epithelia themselves may cause elevated
HLA-class II antigen expression also in GN, although passive
uptake from an extracellular source has not unequivocally be
excluded.
Induction of class II antigens on tubular cells has been
suggested to be primarily mediated by interferon derived from
T-cells as a consequence of their activation [40] in vitro or in
vivo. Phenotyping of interstitial cells in relation to tubular
expression of HLA-DQ or -DP antigens indicated T-lympho-
cytes as the predominant infiltrating cell population in all cases
with RPGN, FGS and MPGN, as well as in the few biopsies of
MesPGN, PGN and ML [32]. Differences in T-cell subpopula-
tions infiltrating the interstitium, as well as acuity and progres-
sion of the disease, could influence induction and persistence of
HLA-class II antigens and thus explain the lack of HLA-DQ
and/or -DP products on tubular cells in some biopsies with these
forms of GN. On the other hand, in several cases of MesPGN,
MCH and PGN, }ILA-DQ and/or -DP antigens were also shown
to be abnormally present on tubular epithelia in the absence of
interstitial infiltrates. This finding suggests that interferons or
mediators from different cell types other than T-cells may also
be involved in lILA-class II induction in various types of GN.
Functional significance of the altered renal HLA-class II
antigen expression in the development of progression of gb-
merulonephritis is at present unknown. Our finding of quanti-
tative or qualitative changes of HLA-class II antigens on
glomerular and tubular cells could be related to specific sites of
immunological attack in different forms of GN. As in allo-
rejection reactions and GvHR of the kidney induction of
HLA-DQ or -DP antigens on tubular epithelia could be the
result of an ongoing immunological attack mediated by T-
lymphocytes. In the absence of interstitial T-cell infiltrates in
some cases of GN, abnormal tubular expression of HLA-DQ or
-DP antigens is suggested to confer induction of an immunolog-
ical process. As seen in infections or autoimmune diseases [41],
aberrant expression of HLA-class II antigens on epithelia of
different organs has been claimed to initiate the immunological
attack and thus bring about the disease [42]. It is tempting to
speculate that altered expression of class II antigens on tubular
epithelia in certain forms of GN could be a sign of immunolog-
ical defence reactions during infections or could cause auto-
reactivity. Kinetic studies of renal damage in relation to HLA-
class II expression may contribute to understanding the
immunological implications of differential distribution and in-
duction of HLA-DQ, -DR, -DP antigens in normal kidney and
GN.
TU 22(HLA-DQ)
TU 34 (HLA-DR)
N MesP ML PGN
RPGN MPGN MCH FGS
C,
Co
CD
E
x0
0.
C0
Co0
B7/21 (HLA-DP)
RPGN MPGN MCH FGS
TU 39 (H LA-OR, -DP, -DY)
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